Abstract
Alzheimer’s disease (AD) is a degenerative disorder of the central nervous system which causes progressive cognitive decline during mid to late adult life. The primary causes of AD have not yet been identified. Mutated genes have been located on chromosomes 21,14, and 1, leading to the early onset familial form of the disease (EOFAD) (Shellenberg, 1995; Sorbi, 1993). The first presenile AD gene encoding for β-amyloid precursor protein (APP) was identified in 1991 (Goate et al., 1991). The most frequent pathogenic mutation in exon 17, a Val-Ile substitution at codon 717, has been described in more than 10 families (Levy-Lahad et al., 1996). The largest portion of early onset FAD cases have been associated with mutations in Presenilin 1 (PS1) gene and Presenilin 2 (PS2) gene (Van Broeckhoven, 1995; Rogaev et al., 1995; Levy-Lahad et al., 1995). Fibroblasts from patients and pre-symptomatic carriers of mutations in PS1 and PS2 contain increased amounts of Aβ 1-42 peptide (Scheuner et al., 1996). Moreover, the allele E4 of APOE gene has been associated with increased risk for late-onset familial form of AD (Saunders et al., 1993). Apolipoprotein E is the first identified genetic susceptibility factor for sporadic AD. The familial AD form account for 10% of all AD cases (Van Broeckhoven, 1995).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bracco, L., Amaducci, L. and the SMID group. Italian multicenter study on dementia, 1992, A protocol for data collection and clinical diagnosis of Alzheimer’s disease. Neuroepidemiology 11:39.
Goate, A., Chartier-Harlin, M.C., Mullan, M, et al., 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704.
Grundke-Iqbal, I., Iqbal, K., Tung, Y-C, Quinlan, M., Wisniewski, H.M. and Binder, L., 1986, Abnormal phos-phorilation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Nail. Acad.Sci.83:4913.
Kumar, U., Dunlop, D.M. and Richardson, J.S., 1994, Mithocondria from Alzheimer’s fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals. Life Sci. 54:1855.
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., et al., 1995, Candidate gene for the chromosome 1 familial Alzheimer’s Disease locus. Science 269:973.
Levy-Lahad, E. and Bird, T.D., 1996, Genetic factors in Alzheimer’s Disease: a review of recent advanced. Ann. Neurol. 40:829.
Liguri, G., Cecchi, C., Latorraca, S., Pieri, A., Sorbi, S., Degl’Innocenti, D. and Ramponi, G., 1996, Alteration of acylphosphatase levels in familial Alzheimer’s disease fibroblasts with presenilin gene mutations. Neuro-sci. Lett. 210:153.
Mattson, M.P., Barger, S.W., Cheng, B., Lieberburg, I., Smith-Swintosky, V.L. and Rydel, R.E., 1993, β-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer’s disease. TINS 16:409.
Nassi, P., Nediani, C., Liguri, G., Taddei, N., Ramponi, G., 1991, Effects of acylphosphatase on the activity of erythrocyte membraneCa2+ pump. J. Biol. Chem. 266:10867.
Nediani, C., Fiorillo, C., Marchetti, E., Pacini, A., Liguri, G. and Nassi, P., 1996, Stimulation of cardiac sarcoplas-mic reticulum calcium pump by acylphosphatase. J. Biol. Chem. 271:19066.
Paoli, P., Camici, G., Manao, G. and Ramponi, G., 1995, 2-Methoxybenzoyl phosphate: a new substrate for continuous fluorimetric acyl phosphate assays. Experientia 51:57.
Parker, W,D., Mahr, M.S., Filley, C.M., Parks, J., Hughes, M.A., Young, D.A. and Cullum, CM., 1994, Electron platelet cytochrome c oxidase activity in Alzheimer’s disease. Neurology 44:1086.
Peterson, C. and Goldman, J.E., 1986, Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. 83:2758.
Querfurth, H.W., and Selkoe, D.J., 1994, Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 33:4550.
Rogaev, E.I., Sherrington, R., Rogaeva, E.A. et al., 1995, Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376:775.
Saunders, A.M., Strittmatter, W.J., Schmechel, D., George-Hyslop, P.H., et al., 1993, Association of Apolipopro-tein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43:1467.
Schellemberg, G.D., 1995, Genetic dissection of Alzheimer Disease, a heterogeneous disorder.Proc. Natl. Acad. Sci. 92:8552.
Scheuner, D., Eckman, C., Jensen, M., Song, X. et al., 1996, Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenitin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat. Med. 2:864.
Sheu, K.F.R., Cooper, A.J.L., Koike, M., Lindsay, J.G. and Blass, J. P., 1994, Abnormality of the a-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer’s disease. Ann. Neurol. 35:312.
Shimohama, S., Fujimoto, S., Taniguchi, T., Kameyama, M., Kimura, J., 1993, Reduction of low-molecular-weight acid phosphatase activity in Alzheimer brains. Ann. Neurol. 33:616.
Sims, N.R., Finegan, J.M. and Blass, J.P., 1987, Alterated metabolic properties of cultured skin fibroblasts in Alzheimer’s disease. Ann. Neurol. 21:451.
Sorbi, S., 1993, Molecular genetics of Alzheimer’s disease, Aging Clin. Exp. Res. 5:417.
Sorbi, S., Piacentini, S., Latorraca, S., Piersanti, P. and Amaducci, L., 1995, Alterations in metabolic properties in fibroblasts in Alzheimer’s disease. Alzheimer. Dis. Assoc. Disord. 9:73.
Stefani, M., Ramponi, G., 1995, Acylphosphate phosphohydrolases. Life Chem. Rep. 12:271.
Van Broeckhoven, C., 1995, Presenilins and Alzheimer disease. Nat. Genet. 11:230.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Latorraca, S., Cecchi, C., Pieri, A., Liguri, G., Amaducci, L., Sorbi, S. (1998). Acylphosphatase Levels In Alzheimer’s Disease Cultured Skin Fibroblasts. In: Fisher, A., Hanin, I., Yoshida, M. (eds) Progress in Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 49. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5337-3_112
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5337-3_112
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7435-0
Online ISBN: 978-1-4615-5337-3
eBook Packages: Springer Book Archive